Versant Vantage I GP, L.P. (CIK 0001777651)

Latest company ownership

Shares held
1,573,453
Last filed at
Oct 30, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q2 2025Q4
PASG - Passage BIO, Inc.
Role: 10% Owner
Shares held
708,352
Last filed at
Mar 3, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q1 2025Q4
Shares held
231,211
Last filed at
Jun 7, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
LVTX - LAVA Therapeutics NV
Role: 10% Owner
Shares held
0
Last filed at
Sep 23, 2025
Confidence Score
40.6
2025Q4
Confidence Score History
2025Q3 2025Q4
Shares held
0
Last filed at
May 20, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 19, 2025 Sep 23, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -2,903,403 -100.00% ✗ $4.1M
Sep 16, 2025 Sep 18, 2025 LAVA Therapeutics NV 10% Owner Sell 17.5 -1,684,434 -36.72% ✗ $2.5M
Oct 28, 2024 Oct 30, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -1,544,352 -12.37% ✗ $1.5M
Sep 20, 2024 Sep 24, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 16.3 -1,132,566 -13.60% ✗ $7.4M
Sep 11, 2024 Sep 13, 2024 Monte Rosa Therapeutics, Inc. 10% Owner Sell 17.5 -567,213 -6.38% ✗ $3.4M
Jun 3, 2022 Jun 7, 2022 Repare Therapeutics Inc. 10% Owner Sell 16.3 -1,450,000 -20.47% ✗ $9.2M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 95.0 +157,895 8.14% ✗ $3M
Jun 23, 2020 Jun 25, 2020 Repare Therapeutics Inc. 10% Owner Buy 96.3 +250,000 6.62% ✗ $5M
Mar 3, 2020 Mar 3, 2020 Passage BIO, Inc. 10% Owner Buy 100.0 +225,000 31.76% ✗ $4.1M
Oct 7, 2019 Oct 7, 2019 Aprea Therapeutics, Inc. 10% Owner Buy 100.0 +333,333 100.00% ✗ $5M